Shastri Karthik, Gao Yue, Davis Seth J, Kimura Kyle S, Patel Priyesh N, Stephan Scott J, Yang Shiayin F
Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Department of Biostatistics, Vanderbilt University, Nashville, Tennessee, USA.
Facial Plast Surg Aesthet Med. 2023 Jan-Feb;25(1):35-39. doi: 10.1089/fpsam.2021.0303. Epub 2022 May 20.
The Nasal Obstruction Symptom Evaluation (NOSE) scale is widely used by clinicians in evaluation of nasal airway obstruction (NAO). To determine normative values for the NOSE scale among both symptomatic and asymptomatic members of the general U.S. population. A survey of NAO symptoms in adults of age 18 years and older was performed. The distribution of NOSE scores among the general population was estimated. Influence of features including age, gender, race, location, and symptomatology on NOSE scores was evaluated. Surveys were completed by 2333 participants. Mean NOSE score was 11 (standard deviation [SD] 11) in the asymptomatic, and 28 (SD 22) in the symptomatic population ( < 0.0001). Increasing age was associated with an increase in scores until 45 years, after which it was associated with decreasing scores. No significant differences were found related to other investigated demographics. Normative ranges for the NOSE scale are established, and are largely consistent with values in the existing literature. NOSE scores do not appear to be influenced by gender, race, or geography, although age should be considered in their interpretation.
鼻阻塞症状评估（NOSE）量表被临床医生广泛用于评估鼻气道阻塞（NAO）。为了确定美国普通人群中有症状和无症状人群的NOSE量表规范值。对18岁及以上成年人的NAO症状进行了一项调查。估计了普通人群中NOSE评分的分布情况。评估了年龄、性别、种族、地理位置和症状等特征对NOSE评分的影响。2333名参与者完成了调查。无症状人群的平均NOSE评分为11（标准差[SD]为11），有症状人群为28（SD为22）（<0.0001）。年龄增长与45岁之前评分增加相关，45岁之后则与评分降低相关。未发现与其他调查的人口统计学特征相关的显著差异。建立了NOSE量表的规范范围，且与现有文献中的值基本一致。尽管在解释NOSE评分时应考虑年龄，但NOSE评分似乎不受性别、种族或地理位置的影响。
